Literature DB >> 21825240

Resting tremor in Parkinson disease: a negative predictor of levodopa-induced dyskinesia.

Stefan Kipfer1, Marianne A Stephan, W M Michael Schüpbach, Pietro Ballinari, Alain Kaelin-Lang.   

Abstract

BACKGROUND: It is unclear whether patients with different clinical subtypes of Parkinson disease (PD) differ in their risk of developing levodopa-induced dyskinesia (LID) and whether resting tremor is negatively correlated with this risk.
OBJECTIVES: To determine whether resting tremor as an initial manifestation of PD negatively correlated with subsequent occurrence and severity of LID and to study the correlations between LID and other epidemiological factors (eg, age at onset of PD and duration of PD).
DESIGN: Logistic regression analysis was used to determine predictive factors of LID. Spearman rank correlations between LID and epidemiological factors and motor signs (including tremor) were calculated.
SETTING: Institutional tertiary referral center for movement disorders. PATIENTS: Cohort of 85 patients with PD. MAIN OUTCOME MEASURE: Occurrence of LID according to the Unified Parkinson Disease Rating Scale part IV.
RESULTS: Resting tremor as an initial manifestation of PD was associated with reduced risk of developing LID independent of other predictors of LID (duration of PD, axial signs, and levodopa dose).
CONCLUSION: Resting tremor as an initial manifestation of PD predicts lower probability of developing LID under levodopa treatment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21825240     DOI: 10.1001/archneurol.2011.147

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  13 in total

1.  Clinical phenotype and risk of levodopa-induced dyskinesia in Parkinson's disease.

Authors:  Alessandra Nicoletti; Giovanni Mostile; Giuseppe Nicoletti; Gennarina Arabia; Giovanni Iliceto; Paolo Lamberti; Roberto Marconi; Letterio Morgante; Paolo Barone; Aldo Quattrone; Mario Zappia
Journal:  J Neurol       Date:  2016-03-10       Impact factor: 4.849

Review 2.  Levodopa-induced dyskinesia: clinical features, incidence, and risk factors.

Authors:  Tai N Tran; Trang N N Vo; Karen Frei; Daniel D Truong
Journal:  J Neural Transm (Vienna)       Date:  2018-07-03       Impact factor: 3.575

3.  Analysis of Motor Complication and Relative Factors in a Cohort of Chinese Patients with Parkinson's Disease.

Authors:  Baihua Sun; Tao Wang; Nianying Li; Jin Qiao
Journal:  Parkinsons Dis       Date:  2020-07-29

4.  Markers of impaired motor and cognitive volition in Parkinson's disease: Correlates of dopamine dysregulation syndrome, impulse control disorder, and dyskinesias.

Authors:  Jared T Hinkle; Kate Perepezko; Liana S Rosenthal; Kelly A Mills; Alexander Pantelyat; Zoltan Mari; Laura Tochen; Jee Yun Bang; Medha Gudavalli; Nadine Yoritomo; Ankur Butala; Catherine C Bakker; Vanessa Johnson; Emile Moukheiber; Ted M Dawson; Gregory M Pontone
Journal:  Parkinsonism Relat Disord       Date:  2017-11-21       Impact factor: 4.891

5.  Parkinson's Disease and development of levodopa induced motor complications: Influence of baseline features and first medical approach.

Authors:  Alexandra Sofia Rua Rafael; Joselina Maria Pinto Barbosa; Maria José Silva Leão Rosas; Maria Carolina Lobo Almeida Garrett
Journal:  Porto Biomed J       Date:  2016-09-17

6.  Spontaneous locomotor activity and L-DOPA-induced dyskinesia are not linked in 6-OHDA parkinsonian rats.

Authors:  Stefania Sgroi; Alain Kaelin-Lang; Christine Capper-Loup
Journal:  Front Behav Neurosci       Date:  2014-10-02       Impact factor: 3.558

Review 7.  Rest tremor revisited: Parkinson's disease and other disorders.

Authors:  Wei Chen; Franziska Hopfner; Jos Steffen Becktepe; Günther Deuschl
Journal:  Transl Neurodegener       Date:  2017-06-16       Impact factor: 8.014

8.  The modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan Africa.

Authors:  Roberto Cilia; Albert Akpalu; Fred Stephen Sarfo; Momodou Cham; Marianna Amboni; Emanuele Cereda; Margherita Fabbri; Patrick Adjei; John Akassi; Alba Bonetti; Gianni Pezzoli
Journal:  Brain       Date:  2014-07-17       Impact factor: 13.501

9.  Cervical skin denervation associates with alpha-synuclein aggregates in Parkinson disease.

Authors:  Giorgia Melli; Elena Vacchi; Vanessa Biemmi; Salvatore Galati; Claudio Staedler; Roberto Ambrosini; Alain Kaelin-Lang
Journal:  Ann Clin Transl Neurol       Date:  2018-10-14       Impact factor: 4.511

10.  Risk factors of levodopa-induced dyskinesia in Parkinson's disease: results from the PPMI cohort.

Authors:  Paolo Eusebi; Michele Romoli; Federico Paolini Paoletti; Nicola Tambasco; Paolo Calabresi; Lucilla Parnetti
Journal:  NPJ Parkinsons Dis       Date:  2018-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.